Current Studies

Rheumatology, Allergy & Immunology

• Beth L. Jonas , MD
  • A Phase I, Double Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Osteogenic Ptotein-1 (OP-1) in Subjects with Moderate to Severe Osteoarthritis of the Knee
  • A Randomized, Double-Blind, Parallel-Group Study of Safety In Osteoarthritis or Rheumatoid Arthritis with or at High Risk for Cardiovascular Disease Comparing Celecoxib with Naproxin and Ibuprofin